Variants in the ABCA4 gene in a Brazilian population with stargardt disease

Mariana Vallim Salles, Fabiana Louise Motta, Renan Martin, Rafael Filippelli-Silva, Elton Dias da Silva, Patricia Varela, Kárita Antunes Costa, Pei-Wen Chiang, João Bosco Pesquero, Juliana Maria Ferraz Sallum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The aim of this study was to analyze and report pathogenic variants in the ABCA4 gene in Brazilian patients with a clinical diagnosis of Stargardt disease. Methods: This retrospective study evaluated variants in the ABCA4 gene in Brazilian patients with Stargardt disease. The patients’ visual acuity and age of symptom onset were obtained from previous medical records. The patients were classified according to the autofluorescence patterns. Results: Fifty patients aged between 10 and 65 years from 44 families were included in the study. Among these cases, the mean age of symptom onset was 14 years (range, 5–40 years). ABCA4 gene sequencing was conclusive in 40 patients (80%), negative in two patients (4%), and inconclusive in eight patients (16%). Four families carried homozygous pathogenic variants. Segregation analysis results were available for 23 families. One novel variant was found: p.Ala2084Pro. The most frequent pathogenic variant in this group was p.Arg602Trp (12/100 alleles). Based on the phenotypic characteristics assessed with fundus autofluorescence imaging, 12 patients were classified as having type I phenotype, 16 as having type II, and 18 patients as having type III. The cases classified as type III phenotype included patients who were homozygous for the p.Asn96Asp and p.Arg2030* variants. One patient with a type I phenotype carried the homozygous intronic variant c.3862+1G>A. Conclusions: Next-generation sequencing was effective for the molecular diagnosis of genetic diseases and specifically allowed a conclusive diagnosis in 80% (40/50) of the patients. As the ABCA4 gene does not show a preferential region for pathogenic variants, the diagnosis of Stargardt disease depends on broader analysis of the gene. The most common pathogenic variants in the ABCA4 gene described in the literature were also found in these Brazilian patients. Although some genotype–phenotype correlations were found, more studies regarding the progression of Stargardt disease will help increase our understanding of the pathogenicity of these gene variants.

Original languageEnglish (US)
Pages (from-to)546-559
Number of pages14
JournalMolecular Vision
Volume24
StatePublished - Aug 1 2018
Externally publishedYes

Fingerprint

Population
Genes
Phenotype
Age of Onset
Stargardt disease 1
Patient Acuity
Inborn Genetic Diseases
Optical Imaging
Visual Acuity
Medical Records
Virulence
Molecular Biology
Retrospective Studies
Alleles

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Salles, M. V., Motta, F. L., Martin, R., Filippelli-Silva, R., da Silva, E. D., Varela, P., ... Sallum, J. M. F. (2018). Variants in the ABCA4 gene in a Brazilian population with stargardt disease. Molecular Vision, 24, 546-559.

Variants in the ABCA4 gene in a Brazilian population with stargardt disease. / Salles, Mariana Vallim; Motta, Fabiana Louise; Martin, Renan; Filippelli-Silva, Rafael; da Silva, Elton Dias; Varela, Patricia; Costa, Kárita Antunes; Chiang, Pei-Wen; Pesquero, João Bosco; Sallum, Juliana Maria Ferraz.

In: Molecular Vision, Vol. 24, 01.08.2018, p. 546-559.

Research output: Contribution to journalArticle

Salles, MV, Motta, FL, Martin, R, Filippelli-Silva, R, da Silva, ED, Varela, P, Costa, KA, Chiang, P-W, Pesquero, JB & Sallum, JMF 2018, 'Variants in the ABCA4 gene in a Brazilian population with stargardt disease', Molecular Vision, vol. 24, pp. 546-559.
Salles MV, Motta FL, Martin R, Filippelli-Silva R, da Silva ED, Varela P et al. Variants in the ABCA4 gene in a Brazilian population with stargardt disease. Molecular Vision. 2018 Aug 1;24:546-559.
Salles, Mariana Vallim ; Motta, Fabiana Louise ; Martin, Renan ; Filippelli-Silva, Rafael ; da Silva, Elton Dias ; Varela, Patricia ; Costa, Kárita Antunes ; Chiang, Pei-Wen ; Pesquero, João Bosco ; Sallum, Juliana Maria Ferraz. / Variants in the ABCA4 gene in a Brazilian population with stargardt disease. In: Molecular Vision. 2018 ; Vol. 24. pp. 546-559.
@article{3d61cd54b739439fae7743e5635ddd8e,
title = "Variants in the ABCA4 gene in a Brazilian population with stargardt disease",
abstract = "Purpose: The aim of this study was to analyze and report pathogenic variants in the ABCA4 gene in Brazilian patients with a clinical diagnosis of Stargardt disease. Methods: This retrospective study evaluated variants in the ABCA4 gene in Brazilian patients with Stargardt disease. The patients’ visual acuity and age of symptom onset were obtained from previous medical records. The patients were classified according to the autofluorescence patterns. Results: Fifty patients aged between 10 and 65 years from 44 families were included in the study. Among these cases, the mean age of symptom onset was 14 years (range, 5–40 years). ABCA4 gene sequencing was conclusive in 40 patients (80{\%}), negative in two patients (4{\%}), and inconclusive in eight patients (16{\%}). Four families carried homozygous pathogenic variants. Segregation analysis results were available for 23 families. One novel variant was found: p.Ala2084Pro. The most frequent pathogenic variant in this group was p.Arg602Trp (12/100 alleles). Based on the phenotypic characteristics assessed with fundus autofluorescence imaging, 12 patients were classified as having type I phenotype, 16 as having type II, and 18 patients as having type III. The cases classified as type III phenotype included patients who were homozygous for the p.Asn96Asp and p.Arg2030* variants. One patient with a type I phenotype carried the homozygous intronic variant c.3862+1G>A. Conclusions: Next-generation sequencing was effective for the molecular diagnosis of genetic diseases and specifically allowed a conclusive diagnosis in 80{\%} (40/50) of the patients. As the ABCA4 gene does not show a preferential region for pathogenic variants, the diagnosis of Stargardt disease depends on broader analysis of the gene. The most common pathogenic variants in the ABCA4 gene described in the literature were also found in these Brazilian patients. Although some genotype–phenotype correlations were found, more studies regarding the progression of Stargardt disease will help increase our understanding of the pathogenicity of these gene variants.",
author = "Salles, {Mariana Vallim} and Motta, {Fabiana Louise} and Renan Martin and Rafael Filippelli-Silva and {da Silva}, {Elton Dias} and Patricia Varela and Costa, {K{\'a}rita Antunes} and Pei-Wen Chiang and Pesquero, {Jo{\~a}o Bosco} and Sallum, {Juliana Maria Ferraz}",
year = "2018",
month = "8",
day = "1",
language = "English (US)",
volume = "24",
pages = "546--559",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Variants in the ABCA4 gene in a Brazilian population with stargardt disease

AU - Salles, Mariana Vallim

AU - Motta, Fabiana Louise

AU - Martin, Renan

AU - Filippelli-Silva, Rafael

AU - da Silva, Elton Dias

AU - Varela, Patricia

AU - Costa, Kárita Antunes

AU - Chiang, Pei-Wen

AU - Pesquero, João Bosco

AU - Sallum, Juliana Maria Ferraz

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Purpose: The aim of this study was to analyze and report pathogenic variants in the ABCA4 gene in Brazilian patients with a clinical diagnosis of Stargardt disease. Methods: This retrospective study evaluated variants in the ABCA4 gene in Brazilian patients with Stargardt disease. The patients’ visual acuity and age of symptom onset were obtained from previous medical records. The patients were classified according to the autofluorescence patterns. Results: Fifty patients aged between 10 and 65 years from 44 families were included in the study. Among these cases, the mean age of symptom onset was 14 years (range, 5–40 years). ABCA4 gene sequencing was conclusive in 40 patients (80%), negative in two patients (4%), and inconclusive in eight patients (16%). Four families carried homozygous pathogenic variants. Segregation analysis results were available for 23 families. One novel variant was found: p.Ala2084Pro. The most frequent pathogenic variant in this group was p.Arg602Trp (12/100 alleles). Based on the phenotypic characteristics assessed with fundus autofluorescence imaging, 12 patients were classified as having type I phenotype, 16 as having type II, and 18 patients as having type III. The cases classified as type III phenotype included patients who were homozygous for the p.Asn96Asp and p.Arg2030* variants. One patient with a type I phenotype carried the homozygous intronic variant c.3862+1G>A. Conclusions: Next-generation sequencing was effective for the molecular diagnosis of genetic diseases and specifically allowed a conclusive diagnosis in 80% (40/50) of the patients. As the ABCA4 gene does not show a preferential region for pathogenic variants, the diagnosis of Stargardt disease depends on broader analysis of the gene. The most common pathogenic variants in the ABCA4 gene described in the literature were also found in these Brazilian patients. Although some genotype–phenotype correlations were found, more studies regarding the progression of Stargardt disease will help increase our understanding of the pathogenicity of these gene variants.

AB - Purpose: The aim of this study was to analyze and report pathogenic variants in the ABCA4 gene in Brazilian patients with a clinical diagnosis of Stargardt disease. Methods: This retrospective study evaluated variants in the ABCA4 gene in Brazilian patients with Stargardt disease. The patients’ visual acuity and age of symptom onset were obtained from previous medical records. The patients were classified according to the autofluorescence patterns. Results: Fifty patients aged between 10 and 65 years from 44 families were included in the study. Among these cases, the mean age of symptom onset was 14 years (range, 5–40 years). ABCA4 gene sequencing was conclusive in 40 patients (80%), negative in two patients (4%), and inconclusive in eight patients (16%). Four families carried homozygous pathogenic variants. Segregation analysis results were available for 23 families. One novel variant was found: p.Ala2084Pro. The most frequent pathogenic variant in this group was p.Arg602Trp (12/100 alleles). Based on the phenotypic characteristics assessed with fundus autofluorescence imaging, 12 patients were classified as having type I phenotype, 16 as having type II, and 18 patients as having type III. The cases classified as type III phenotype included patients who were homozygous for the p.Asn96Asp and p.Arg2030* variants. One patient with a type I phenotype carried the homozygous intronic variant c.3862+1G>A. Conclusions: Next-generation sequencing was effective for the molecular diagnosis of genetic diseases and specifically allowed a conclusive diagnosis in 80% (40/50) of the patients. As the ABCA4 gene does not show a preferential region for pathogenic variants, the diagnosis of Stargardt disease depends on broader analysis of the gene. The most common pathogenic variants in the ABCA4 gene described in the literature were also found in these Brazilian patients. Although some genotype–phenotype correlations were found, more studies regarding the progression of Stargardt disease will help increase our understanding of the pathogenicity of these gene variants.

UR - http://www.scopus.com/inward/record.url?scp=85051683548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051683548&partnerID=8YFLogxK

M3 - Article

C2 - 30093795

AN - SCOPUS:85051683548

VL - 24

SP - 546

EP - 559

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -